Evidence map›Paper›PMID 20045004›Full record

ArticleJournal of molecular and cellular cardiology2010

Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation.

Susan Chung, D Kent Arrell, Randolph S Faustino, Andre Terzic, Petras P Dzeja

Abstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 167 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Metabolic control of induced pluripotency.Frontiers in cell and developmental biology · 2023
    Review
  11. Article
  12. International journal of molecular sciences · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Maturing heart muscle cells: Mechanisms and transcriptomic insights.Seminars in cell & developmental biology · 2021
    Review
  18. Review
  19. Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Susan ChungMarriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street SW, Stabile 5, Rochester, MN 55905, USA.
D Kent Arrell
Randolph S Faustino
Andre Terzic
Petras P Dzeja
WinnMed · USMayo Clinic · US

Funding

Adenylate Kinase in Heart Energetics and Metabolic SignalingR01HL085744 · NHLBI · MAYO CLINIC ROCHESTER · PI DZEJA, PETRAS P · 2007 to 2016
$3.4M
Cardioprotective Repair through CardiopoiesisR01HL083439 · NHLBI · MAYO CLINIC ROCHESTER · PI TERZIC, ANDRE · 2006 to 2010
$1.8M
NHLBI NIH HHS HL083439NHLBI NIH HHS HL 85744NHLBI NIH HHS R01 HL083439NHLBI NIH HHS R01 HL085744
6 · The paper itself

Abstract

Decoding of the bioenergetic signature underlying embryonic stem cell cardiac differentiation has revealed a mandatory transformation of the metabolic infrastructure with prominent mitochondrial network expansion and a distinctive switch from glycolysis to oxidative phosphorylation. Here, we demonstrate that despite reduction in total glycolytic capacity, stem cell cardiogenesis engages a significant transcriptome, proteome, as well as enzymatic and topological rearrangement in the proximal, medial, and distal modules of the glycolytic pathway. Glycolytic restructuring was manifested by a shift in hexokinase (Hk) isoforms from Hk-2 to cardiac Hk-1, with intracellular and intermyofibrillar localization mapping mitochondrial network arrangement. Moreover, upregulation of cardiac-specific enolase 3, phosphofructokinase, and phosphoglucomutase and a marked increase in glyceraldehyde 3-phosphate dehydrogenase (GAPDH) phosphotransfer activity, along with apparent post-translational modifications of GAPDH and phosphoglycerate kinase, were all distinctive for derived cardiomyocytes compared to the embryonic stem cell source. Lactate dehydrogenase (LDH) isoforms evolved towards LDH-2 and LDH-3, containing higher proportions of heart-specific subunits, and pyruvate dehydrogenase isoforms rearranged between E1alpha and E1beta, transitions favorable for substrate oxidation in mitochondria. Concomitantly, transcript levels of fetal pyruvate kinase isoform M2, aldolase 3, and transketolase, which shunt the glycolytic with pentose phosphate pathways, were reduced. Collectively, changes in glycolytic pathway modules indicate active redeployment, which would facilitate connectivity of the expanding mitochondrial network with ATP utilization sites. Thus, the delineated developmental dynamics of the glycolytic phosphotransfer network is integral to the remodeling of cellular energetic infrastructure underlying stem cell cardiogenesis.

Indexed as

AnimalsCell DifferentiationElectrophoresis, Gel, Two-DimensionalEmbryonic Stem CellsGene Expression ProfilingGlyceraldehyde-3-Phosphate DehydrogenasesGlycolysisImage Processing, Computer-AssistedL-Lactate DehydrogenaseMetabolomicsMicePentose Phosphate PathwayPhosphoglycerate KinaseProtein IsoformsProtein Processing, Post-TranslationalGlyceraldehyde-3-Phosphate DehydrogenasesL-Lactate DehydrogenasePhosphoglycerate KinaseProtein Isoformsbioenergeticscardiogenesisembryonic stem cellsproteomicstranscriptome

Identifiers

PMID20045004
PMCPMC2837789
OpenAlexW2037177911

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.